Formulation optimization of solid self-microemulsifying pellets for enhanced oral bioavailability of curcumin

References

• Adiwidjaja J, McLachlan AJ, Boddy AV. 2017. Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions. Expert Opin Drug Metab Toxicol. 13(9):953–972. eng.
   PubMed Web of Science ®Google Scholar
• Arya P, Pathak K. 2014. Assessing the viability of microsponges as gastro retentive drug delivery system of curcumin: optimization and pharmacokinetics. Int J Pharm. 460(1–2):1–12. eng.
   PubMed Web of Science ®Google Scholar
• Balbaa M, El-Zeftawy M, Taha N, Mandour AW. 2017. Zinc and curcumin lower arylsulfatses and some metabolic parameters in streptozotocin-induced diabetes. J Diabetes Metab Disord. 16(1):11–11.
   PubMedGoogle Scholar
• Chen M, Du Z-Y, Zheng X, Li D-L, Zhou R-P, Zhang K. 2018. Use of curcumin in diagnosis, prevention, and treatment of Alzheimer’s disease. Neural Regen Res. 13(4):742–752.
   PubMed Web of Science ®Google Scholar
• Danafar H, Davaran S, Rostamizadeh K, Valizadeh H, Hamidi M. 2014. Biodegradable m-PEG/PCL core-shell micelles: preparation and characterization as a sustained release formulation for curcumin. Adv Pharm Bull. 4(Suppl 2):501–510.
   PubMedGoogle Scholar
• Dempe JS, Scheerle RK, Pfeiffer E, Metzler M. 2013. Metabolism and permeability of curcumin in cultured Caco-2 cells. Mol Nutr Food Res. 57(9):1543–1549. eng.
   PubMed Web of Science ®Google Scholar
• Dokania S, Joshi AK. 2015. Self-microemulsifying drug delivery system (SMEDDS) – challenges and road ahead. Drug Deliv. 22(6):675–690.
   PubMed Web of Science ®Google Scholar
• Garba ZN, Lawan I, Zhou W, Zhang M, Wang L, Yuan Z. 2020. Microcrystalline cellulose (MCC) based materials as emerging adsorbents for the removal of dyes and heavy metals – a review. Sci Total Environ. 717:135070.
   PubMed Web of Science ®Google Scholar
• Gong Z, Zhao S, Zhou J, Yan J, Wang L, Du X, Li H, Chen Y, Cai W, Wu J. 2018. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production. Mol Immunol. 104:11–19.
   PubMed Web of Science ®Google Scholar
• Guan Q, Zhang G, Sun S, Fan H, Sun C, Zhang S. 2016. Enhanced oral bioavailability of pueraria flavones by a novel solid Self-Microemulsifying Drug Delivery System (SMEDDS) dropping pills. Biol Pharm Bull. 39(5):762–769.
   PubMed Web of Science ®Google Scholar
• Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Topkaya AE. 2016. Antibacterial effects of curcumin. Toxicol Ind Health. 32(2):246–250.
   PubMed Web of Science ®Google Scholar
• He H, Lu Y, Qi J, Zhu Q, Chen Z, Wu W. 2019. Adapting liposomes for oral drug delivery. Acta Pharm Sin B. 9(1):36–48.
   PubMed Web of Science ®Google Scholar
• Hu X, Lin C, Chen D, Zhang J, Liu Z, Wu W, Song H. 2012. Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int J Pharm. 438(1–2):123–133.
   PubMed Web of Science ®Google Scholar
• Hussain Z, Thu HE, Amjad MW, Hussain F, Ahmed TA, Khan S. 2017. Exploring recent developments to improve antioxidant, anti-inflammatory and antimicrobial efficacy of curcumin: a review of new trends and future perspectives. Mater Sci Eng C Mater Biol Appl. 77:1316–1326.
   PubMed Web of Science ®Google Scholar
• Hussain Z, Thu HE, Ng SF, Khan S, Katas H. 2017. Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: a review of new trends and state-of-the-art. Colloids Surf B Biointerfaces. 150:223–241.
   PubMed Web of Science ®Google Scholar
• Karwal R, Garg T, Rath G, Markandeywar TS. 2016. Current trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to enhance the bioavailability of poorly water-soluble drugs. Crit Rev Ther Drug Carrier Syst. 33(1):1–39.
   PubMed Web of Science ®Google Scholar
• Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. 2012. Potentials and challenges in self-nanoemulsifying drug delivery systems. Expert Opin Drug Deliv. 9(10):1305–1317. eng.
   PubMed Web of Science ®Google Scholar
• Lelli D, Sahebkar A, Johnston TP, Pedone C. 2017. Curcumin use in pulmonary diseases: state of the art and future perspectives. Pharmacol Res. 115:133–148.
   PubMed Web of Science ®Google Scholar
• Li H, Sureda A, Devkota HP, Pittalà V, Barreca D, Silva AS, Tewari D, Xu S, Nabavi SM. 2020. Curcumin, the golden spice in treating cardiovascular diseases. Biotechnol Adv. 38:107343.
   PubMed Web of Science ®Google Scholar
• Li X, Xu DQ, Sun DY, Zhang T, He X, Xiao DM. 2019. Curcumin ameliorates monosodium urate-induced gouty arthritis through Nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa B signaling. J Cell Biochem. 120(4):6718–6728.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhai Y, Heng X, Che FY, Chen W, Sun D, Zhai G. 2016. Oral bioavailability of curcumin: problems and advancements. J Drug Target. 24(8):694–702.
   PubMed Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. 2007. Curcumin–phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm. 330(1–2):155–163.
   PubMed Web of Science ®Google Scholar
• Mendonsa N, Almutairy B, Kallakunta VR, Sarabu S, Thipsay P, Bandari S, Repka MA. 2020. Manufacturing strategies to develop amorphous solid dispersions: an overview. J Drug Delivery Sci Technol. 55:101459.
   PubMed Web of Science ®Google Scholar
• Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. 2017. The essential medicinal chemistry of curcumin. J Med Chem. 60(5):1620–1637.
   PubMed Web of Science ®Google Scholar
• Nikolakakis I, Partheniadis I. 2017. Self-emulsifying granules and pellets: composition and formation mechanisms for instant or controlled release. Pharmaceutics. 9(4):50–50.
   Web of Science ®Google Scholar
• Pan G, Jia X, Wei H, Wang Y. 2006. Comparison among several preparation methods for pseudo -ternary phase diagrams of pharmaceutical microemulsions. China Pharmacy. 17(1):21–23.
   Google Scholar
• Qi X, Qin J, Ma N, Chou X, Wu Z. 2014. Solid self-microemulsifying dispersible tablets of celastrol: Formulation development, charaterization and bioavailability evaluation. Int J Pharm. 472(1–2):40–47.
   PubMed Web of Science ®Google Scholar
• Sahebkar A, Cicero AFG, Simental-Mendía LE, Aggarwal BB, Gupta SC. 2016. Curcumin downregulates human tumor necrosis factor-α levels: a systematic review and meta-analysis ofrandomized controlled trials. Pharmacol Res. 107:234–242.
   PubMed Web of Science ®Google Scholar
• Setthacheewakul S, Mahattanadul S, Phadoongsombut N, Pichayakorn W, Wiwattanapatapee R. 2010. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm. 76(3):475–485.
   PubMed Web of Science ®Google Scholar
• Shin MS, Yu JS, Lee J, Ji YS, Joung HJ, Han YM, Yoo HH, Kang KS. 2019. A hydroxypropyl methylcellulose-based solid dispersion of curcumin with enhanced bioavailability and its hepatoprotective activity. Biomolecules. 9(7):281. eng.
   Web of Science ®Google Scholar
• Song I-S, Cha J-S, Choi M-K. 2016. Characterization, in vivo and in vitro evaluation of solid dispersion of curcumin containing d-α-tocopheryl polyethylene glycol 1000 succinate and mannitol. Molecules. 21(10):1386.
   PubMed Web of Science ®Google Scholar
• Suram D, Narala A, Veerabrahma K. 2020. Development, characterization, comparative pharmacokinetic and pharmacodynamic studies of iloperidone solid SMEDDS and liquisolid compact. Drug Dev Ind Pharm. 46(4):587–596.
   PubMed Web of Science ®Google Scholar
• Verma K, Prasad J, Saha S, Sahu S. 2019. Formulation and evaluation of curcumin loaded liposome and its bio-enhancement. J Drug Delivery Ther. 9(4–A):425–437.
   Google Scholar
• Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK. 1997. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 15(12):1867–1876. eng.
   PubMed Web of Science ®Google Scholar
• Yadav YC, Pattnaik S, Swain K. 2019. Curcumin loaded mesoporous silica nanoparticles: assessment of bioavailability and cardioprotective effect. Drug Dev Ind Pharm. 45(12):1889–1895.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, Xie S. 2010. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed. 99(3):306–314.
   PubMed Web of Science ®Google Scholar
• Zhong W, Qian K, Xiong J, Ma K, Wang A, Zou Y. 2016. Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling. Biomed Pharmacother. 83:302–313. eng.
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhao B, Xiong P, Wang C, Zhang J, Tian X, Huang Y. 2018. Curcumin induces autophagy via Inhibition of Yes-Associated Protein (YAP) in human colon cancer cells. Med Sci Monit. 24:7035–7042.
   PubMed Web of Science ®Google Scholar